Monopar Therapeutics - 09 Dec 2024 SCHEDULE 13D/A Report for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR)

Filing Manager
Monopar Therapeutics
Reporting Manager
Hendricks Diane
Security
Gem Pharmaceuticals LLC Common Stock, $0.001 par value
Symbol
MNPR
Shares outstanding
5.26M shares
Disclosed Ownership
705K shares
Ownership
13.4%
Form type
SCHEDULE 13D/A
Filing time
07 Feb 2025, 17:01:45 UTC
Date of event
09 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Monopar Therapeutics 11.6% 611K 611K 0 Karl Leo Managing Member 0001645469
Hendricks Diane 13.4% 705K 93.8K 611K Diane Hendricks Diane Hendricks 0001727478
Leo Karl 13.4% 642K 31.3K 611K Karl Leo Karl Leo 0001727480
Pharma Investments LLC 11.6% 611K 0 611K Diane Hendricks Managing Member 0001727496